News

nRichDX and Eppendorf to Jointly Present at ESHG 2022 Meeting

IRVINE, California, April 14, 2022 – nRichDX and Eppendorf will present data from the Revolution Semi-Automated Workflow™ powered by the epMotion® 5073 instrument at the upcoming European Society for Human Genetics (ESHG) 2022 Conference in Vienna, Austria on Saturday, June 11, 2022, from 10:00 am – 11:30 am CET....

nRichDX Launches Revolution Sample Prep™ Service

New cfDNA and ctDNA extraction service for researcher-provided blood and urine samples with TAT of one week or less....

nRichDX Introduces In Kind Grants for Academic Researchers

Grant program for qualified and approved cfDNA Researchers in academia and non-profit organizations for the purpose of advancing their research projects by providing more cfDNA and ctDNA than is available using current methods.   IRVINE, Calif., Jun 8, 2021– nRichDX® Inc. announces the Revolution™ Sample Prep Grant Program which provides grants of Processor hardware and Revolution kits to researchers extracting circulating free DNA and circulating tumor DNA in their work. The Revolution Sample Prep System enables the extraction of more cfDNA and ctDNA from samples of blood or urine. The System extracts from 1 mL - 20 mL in a single extraction and unlike other methods, does not require cfDNA yield-lowering sample pooling,  concentration, or transfer steps....

nRichDX Launches Revolution Sample Prep Semi-Automated Workflow

New workflow automates key steps in the extraction of cfDNA and ctDNA from blood and urine samples - an essential step in the development of liquid-based assays.   IRVINE, Calif., Jan. 27, 2021– nRichDX® Inc. announces the launch of its Semi-Automated Revolution™ Sample Prep Workflow powered by Eppendorf for extraction of cfDNA and ctDNA from a wide range of input sample volumes from 3 mL-20 mL with market-leading yields and recovery rates of 70%-90%....

nRichDx Targets Liquid Biopsy Space With Magnetic Sample Prep Platform

Article Published by GenomeWeb (New York, NY. October 23, 2019) – Launching its semi-automated magnetic-based sample prep platform...

nRichDX Introduces High-Yield Sample Prep for Liquid Biopsies

(Irvine, CA. September 20, 2019) – nRichDX Inc. announces the launch of its Revolution™ System, a high-yield sample...

Corporate Advisory Board Formation

(Irvine, CA.  August 1, 2019) – nRichDX Inc. is pleased to announce the formation of a Corporate Advisory...

Massachussetts General Hospital Cancer Center to Participate in Evaluation of nRichDX Revolution System

  (Irvine, CA.  April 24, 2019) – nRichDX Inc. is pleased to confirm that, under the direction of Ryan...

Dartmouth-Hitchcock Medical Center To Participate in Evaluation of nRichDX Revolution System

(Irvine, CA.  April 19, 2019) – nRichDX Inc. is pleased to confirm that, under the direction of Gregory...

Scientific Advisory Board Formation

(Irvine, CA.  December 1, 2019) – nRichDX Inc. is pleased to announce the formation of our Scientific Advisory...

Events

nRichDx to Exhibit at the AMP 2022 Annual Meeting & Expo

See nRichDX at the AMP 2022 Annual Meeting and Expo on November 1-5 2022. See the latest in cfDNA and ctDNA extraction with the Revolution Sample Prep System....

nRichDX to Exhibit at the 13th Annual CGC Meeting 2022

Join nRichDX at the upcoming Cancer Genomics Consortium (CGC) 13th Annual Meeting in St. Louis, MO, 31 July - 3 August 2022. The CGC Annual Meeting is a unique gathering aimed at bringing the clinical genomics community together to create an environment of collaboration, education and networking. With the continuing and evolving partnerships between cytogeneticists molecular geneticists, pathologists, oncologists, and bioinformaticians, CGC is committed to playing an essential role in providing guidance on the best practice of genomic testing....

nRichDx Announces Unveiling of Revolution System™ at 2019 AMP Annual Meeting

Increase liquid biopsy-based test sensitivity by delivering exponentially more target input for molecular assays  ...